Coldstream Capital Management Inc Xenon Pharmaceuticals Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 648 shares of XENE stock, worth $24,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
648Holding current value
$24,325% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
222Shares Held
69.6MCall Options Held
194KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$213 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$170 Million1.73% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$142 Million0.03% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$116 Million0.02% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$109 Million6.4% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.34B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...